FENC
$8.22
Fennec Pharmaceuticals
$.17
2.11%
FENC
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.15)
Revenue:  $3.12 Mil
Thursday
Aug 10
7:10 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when FENC reports earnings?
Beat
Meet
Miss

Where is FENC's stock price going from here?
Up
Flat
Down
Stock chart of FENC
Analysts
Summary of analysts' recommendations for FENC
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Company's products include Eniluracil and Sodium Thiosulfate (STS). Fennec Pharmaceuticals Inc., formerly known as Adherex Technologies Inc., is based in United States.